SEARCH

SEARCH BY CITATION

References

  • Beeleen, D.W., Elmaagacli, A., Müller, K.-D., Hirche, H., Schaefer, U.W. (1999) Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomized trial. Blood, 93, 32673275.
  • Bergan, T., Dalhoff, A., Rohwedder, R. (1988) Pharmacokinetics of ciprofloxacin. Infection, 16, 313.
  • Cometta, A., Calandra, T., Bille, J., Glauser, M.P. (1994) E Coli resistant to fluoroquinolones in patients with cancer and neutropenia. New England Journal of Medicine, 330, 12401241.
  • D'Amico, R., Pifferi, S., Leonetti, C., Torri, V., Tinazzi, A., Liberati, A. (1998) Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomized controlled trials. British Medical Journal, 316, 12751285.
  • Dekker, A.W., Rozenberg-Arska, M., Verhoef, J. (1987) Infection prophylaxis in acute leukaemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. Annals of Internal Medicine, 106, 712.
  • Engels, E.A., Lau, J., Barza, M. (1998) Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis. Journal of Clinical Oncology, 16, 11791187.
  • EORTC International Antimicrobial Therapy Project Group (1978) Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. Journal of Infectious Diseases, 137, 1429.
  • Fass, R.J. (1983) In vitro activity of ciprofloxacin (Bay 0, 9867). Antimicrobial Agents and Chemotherapy, 24, 568574.
  • Ferrera, J.L. (1993) Cytokine dysregulation as a mechanism of graft versus host disease. Current Opinion in Immunology, 5, 794800.
  • Ford, C.D., Reilly, W., Wood, J., Classen, D.C., Burke, J.P. (1998) Oral antimicrobial prophylaxis in bone marrow transplant recipients: randomized trial of ciprofloxacin verses ciprofloxacin-vancomycin. Antimicrobial Agents and Chemotherapy, 42, 14021405.
  • GIMEMA Infection Program (1991) Prevention of bacterial infection in neutropenic patients with haematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. Annals of Internal Medicine, 115, 712.
  • Gratwohl, A., Passweg, J., Baldomero, H., Hermans, J. (1998) Influence of protective isolations on outcome of allogeneic BMT for leukaemia. Bone Marrow Transplantation, 21, 12311239.
  • Hargrave, D.R., Hann, I.M., Richards, S.M., Hill, F.G., Lilleyman, J.S., Kinsey, S., Bailey, C.C., Chessells, J.M., Eden, O.B. (2001) Progressive reduction in treatment-related deaths in MRC childhood ALL trials from 1980 to 1997. British Journal Haematology, 112, 293299.
  • Imrie, K.R., Prince, H.M., Couture, F., Brandwein, J.M., Keating, A. (1995) Effect of antimicrobial prophylaxis following auto BMT: ciprofloxacin versus co-trimoxazole. Bone Marrow Transplantation, 15, 267270.
  • Jagarlamundi, R., Kumar, L., Kochupillai, V., Kapil, A., Banerjee, U., Thulkar, S. (2000) Infections in acute leukaemia. an analysis of 240 febrile episodes. Medical Oncology, 17, 111116.30.
  • Karp, J.E., Merz, W.G., Hendricksen, C., Laughon, B., Redden, T., Bamberger, B.J., Bartlett, J.G., Saral, R., Burke, P.J. (1987) Oral norfloxacin for prevention of Gram-negative bacterial infections in patients with acute leukaemia and granulocytopenia: a randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine, 106, 17.
  • Kern, W.V., Andriof, E., Oethinger, M., Kern, P., Hacker, J., Marre, R. (1994) Emergence of fluoroquinolone-resistant Escherichia coli at a cancer centre. Antimicrobial Agents and Chemotherapy, 38, 681687.
  • Kibbler, C.C. & Prentice, H.G. (1999) Pathogen shift in febrile neutropenia. Current Opinion In Infectious Disease, 12, 351353.
  • Lew, M.A., Kehoe, K., Ritz, J., Antman, K.H., Nadler, L., Kalish, L.A., Finbar, R. (1995) Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial. Journal of Clinical Oncology, 13, 239250.
  • Lowder, J.N., Lazarus, H.M., Herzig, R.H. (1982) Bacteremias and fungemias in oncologic patients with central venous catheters: changing spectrum of infection. Archives of Internal Medicine, 142, 14561459.
  • Mannan, P., Kibbler, C.C., Noone, P. (1988) Activity of ciprofloxacin and colistin against Pseudomonas aeruginosa isolates from neutropenic patients: a possible approach to prophylaxis. Journal of Antimicrobial Chemotherapy, 22, 953954.
  • McWhinney, P.H.M., Cunningham, J.M., Kiblber, C.C., Prentice, H.G. (1991) Oral complications of cancer. British Medical Journal, 302, 848.
  • O'Donnell, M.R., Schmidt, G.M., Tegtmeier, B.R. (1994) Prediction of systemic fungal infection in allogeneic marrow recipients. Journal of Clinical Oncology, 12, 827834.
  • Riley, L.C., Hann, I.M., Wheatley, K., Stevens, R.F. (1999) Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the MRC AML 10 trial. British Journal of Haematology, 106, 436444.
  • Rossi, C. & Klastersky, J. (1996) Initial antibiotic therapy for neutropenic fever. Support Care Cancer, 4, 207212.
  • Rozenberg-Arska Mdekker, A.W. & Verhoef, J. (1983) Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease in the emergence of resistant bacteria. Infection, 11, 167169.
  • Rozenberg-Arska Mdekker, A.W. & Verhoef, J. (1985) Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukaemia during remission induction treatment: the effect on faecal flora. Journal of Infectious Diseases, 152, 104107.
  • Schmeiser, T., Kern, W.V., Hay, B., Hertstein, B., Arnold, R. (1993) Single-drug oral antibacterial prophylaxis with ofloxacin in BMT recipients. Bone Marrow Transplantation, 12, 5763.
  • Schimpff, S.C. (1980) Infection prevention during profound granulocytopenia. Annals of Internal Medicine, 93, 358361.
  • Schimpff, S.C., Greene, W.H., Young, V.W., Wiernik, P.H. (1972) Origin of infection in acute non-lymphocytic leukaemia. Significance of hospital acquisition of potential pathogens. Annals of Internal Medicine, 77, 707714.
  • Stokes, E.J. & Ridgeway, G.L. (1987) Clinical Microbiology. 6th edn. Edward Arnold, London. ISBN 0–7131–4532–3.
  • Storring, R.A., Jameson, B., Mcelwain, T.J., Wiltshaw, E. (1977) Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukaemia. Lancet, 2, 837840.
  • Van Der Waaij, D. & Berghuis, J.M. (1974) Determination of the colonization resistance of the digestive tract of individual mice. Journal of Hygiene (Cambridge), 72, 379387.
  • Wade, J.C., Schimpff, S.C., Hargadon, M.T., Fortner, C.L., Young, V.M., Wiernik, P.H. (1981) A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukaemia. New England Journal of Medicine, 304, 10571062.
  • Wade, J.C., De Jongh, C.A., Newman, K.A., Crowley, J., Wiernik, P.H., Schimpff, S.C. (1983) Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: Trimethoprim-sulfamethoxazole vs nalidixic acid. Journal of Infectious Diseases, 147, 624634.
  • Warren, R.E., Wimperis, J.Z., Baglin, T.P., Constantine, C.E., Marcus, R. (1990) Prevention of infection by ciprofloxacin in neutropenia. Journal of Antimicrobial Chemotherapy, 26, 109123.
  • Waterworth, P.M. (1978) In: Laboratory Methods in Antimicrobial Chemotherapy (ed. by D.S.Reeves, I.Phillip, J.D.Williams & R. Wise), pp. 3140. Churchill Livingstone, Edinburgh.
  • Watson, J.G., Powles, R.L., Lawson, D.N., Morgenstern, G.R., Jameson, B., Mcelwain, T.J., Judson, I., Lumley, H., Kay, H.E.M. (1982) Co-trimoxazole versus non-absorbable antibiotics in acute leukaemia. Lancet, 1, 69.
  • Yeh, S.-P., Hsueh, E.-J., Yu, M.-S., Wu, H., Wang, Y.-C. (1999) Oral ciprofloxacin as antibacterial prophylaxis after allo-BMT: a reappraisal. Bone Marrow Transplantation, 24, 12071211.
  • Young, L.S. (1983) Antimicrobial prophylaxis against infection in neutropenic patients (Editorial). Journal of Infectious Diseases, 147, 611614.
  • Young, L.S. (1987) The new fluorinated quinolones for infection prophylaxis in acute leukaemia (Editorial). Annals of Internal Medicine, 106, 144146.